Stay updated on Arimoclomol in Myositis-Open Label Extension Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.

Latest updates to the Arimoclomol in Myositis-Open Label Extension Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe new screenshot shows the same record history page with identical version entries and no visible updates to the trial's core details (status, description, or eligibility). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference11%

- Check45 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0 to reflect the new software version.SummaryDifference0.3%

- Check60 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.SummaryDifference0.7%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.7%

- Check74 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference17%

Stay in the know with updates to Arimoclomol in Myositis-Open Label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.